CTOs on the Move

Spectrum Pharmaceuticals

www.sppirx.com

 
Spectrum`s core mission is to bring pharmaceutical products to patients for unmet medical needs. To this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. Spectrum and its subsidiaries have six marketed oncology/hematology products, three for different types of non-Hodgkins lymphoma, one for advanced metastatic colorectal cancer, one for a certain type of acute lymphoblastic leukemia (ALL) and one for multiple myeloma. There are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.sppirx.com
  • 11500 S Eastern Ave Ste 240
    Henderson, NV USA 89052
  • Phone: 702.835.6300

Executives

Name Title Contact Details

Funding

Spectrum Pharmaceuticals raised $20M on 01/04/2022

Similar Companies

Forefront Dermatology

Forefront Dermatology is a leading dermatology group practice with numerous convenient locations throughout the United States. Find a dermatologist near me today.

Elixir

Elixir, (formerly EnvisionRxOptions) a wholly owned subsidiary of Rite Aid, is a pharmacy benefits and services company with the unique ability to optimize the full pharmacy care experience.

The Pharmacy Examination Board of Canada

The Pharmacy Examination Board of Canada is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioXcel Therapeutics

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company`s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. The company`s two most advanced clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.

Focus Express Mail Pharmacy Inc

Focus Express Mail Pharmacy Inc is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.